APRE

Price-

Market Cap7.38 M

Float13.46 M

Country-

Sector-

Exchange-

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

APRE

Sector

-

Industry

-

Country

-

Exchange

Vol Avg.

N/A

Inst Own

15.400%

Float & OS

13.46 M / 14.19 M

Cash/Shr

Market Cap & Ev

Short Interest

4.6%

Borrow Rate

13.0816%

Days to Cover

2.23

Overall Offering Risk

Warrant Exercise Risk

Research Report

Customize research

Recent Articles (8)

Aprea Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

Globe Newswire

Nov 5, 2026, 4:05 PM

Aprea Therapeutics Announces Third Quarter 2026 Financial Results

Globe Newswire

Nov 4, 2026, 8:30 AM

Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology

Globe Newswire

Oct 16, 2026, 8:30 AM

Aprea Therapeutics to Present at October Conferences

Globe Newswire

Oct 5, 2026, 8:30 AM

Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium

Globe Newswire

Sep 22, 2026, 8:30 AM

Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

Globe Newswire

Sep 10, 2026, 8:00 AM

Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs

Globe Newswire

Aug 28, 2026, 8:15 AM

Aprea Therapeutics Announces Second Quarter 2026 Financial Results

Globe Newswire

Aug 12, 2026, 8:30 AM

Recent Filings

Type	Title	Date Released

Earnings

Mar

30

Q1 2027 Earnings reportUpcoming

Mar

15

Q1 2027 Earnings reportUpcoming

Nov

4

Q4 2026 Earnings report

-0.09%missed

Aug

12

Q3 2026 Earnings report

-0.07%beat

May

13

Q2 2026 Earnings report

-0.22%beat

Mar

16

Q1 2026 Earnings report

-0.32%beat